UAB Aconitum actively carries out the search and development of new export markets. For this purpose, the company implemented the project funded by the European Regional Development Fund “The Development of Export of Lithuanian Pharmaceuticals and Food Supplements” (No 03.2.1-LVPA-K-801-02-0349).
The aim of the project is the growth of export sales. To achieve this aim, during the implementation of the project (within 18 months), the company and its products were presented in 9 international pharmaceutical exhibitions in Europe, USA and Asia: Germany, Italy, France, Vietnam, Azerbaijan, Russia, USA and twice in UAE.
This project is funded under 2014–2020 European Union Funds Investment Program Priority 3 “Promotion of Competitiveness of Small and Medium Business” implementing measure No 03.2.1-LVPA-K-801 “New Possibilities”.